Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Muscle Atrophy or Weakness: early-phase trial registry

3 of 3 indexed Muscle Atrophy or Weakness trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Muscle Atrophy or Weakness: 3 US clinical trials tracked, 3 recruiting.

Muscle Atrophy or Weakness is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Oregon, running 1 of these trials.

Enrollment posture brief

Registry condition muscle-atrophy-or-weakness

OPEN 3 | RECR 100% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Muscle Atrophy or Weakne (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Muscle Atrophy or Weakness

Muscle Atrophy or Weakness lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Muscle Atrophy or Weakness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Muscle Atrophy or Weakness is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Muscle Atrophy or Weakness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fatiguing Exercise Behavioral
1 trials
Yoomi Physical Therapy Software Device
1 trials
Metformin Drug
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Muscle Atrophy or Weakness trials. A trial with sites in several states counts in each.

Utah 1 trials
Oregon 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Muscle Atrophy or Weakness page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Muscle Atrophy or Weakness trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Oregon sponsors the most Muscle Atrophy or Weakness trials on record, review their full trial history before evaluating a specific study. See University of Oregon's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Muscle Atrophy or Weakness condition card totals 3 registered trials; most-linked intervention Fatiguing Exercise; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.